{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:05:02Z","timestamp":1790665502570,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijantimicag.2020.105911","type":"journal-article","created":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T11:35:10Z","timestamp":1579952110000},"page":"105911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Molecular basis of antimicrobial resistance in Mycoplasma genitalium"],"prefix":"10.1016","volume":"55","author":[{"given":"Thomas E.","family":"van der Schalk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce F.","family":"Braam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Kusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105911_bib0001","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/ije\/dyv194","article-title":"Epidemiology of Mycoplasma genitalium in British men and women aged 16\u201344 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)","volume":"44","author":"Sonnenberg","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0002","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/sti.2006.022970","article-title":"Mycoplasma genitalium: prevalence and behavioural risk factors in the general population","volume":"83","author":"Andersen","year":"2007","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0003","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10096-017-2969-9","article-title":"Multidrug-resistant Mycoplasma genitalium infections in Europe","volume":"36","author":"Braam","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sti.2004.012062","article-title":"Mycoplasma genitalium: prevalence, clinical significance, and transmission","volume":"81","author":"Anagrius","year":"2005","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0006","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1073\/pnas.93.19.10268","article-title":"A minimal gene set for cellular life derived by comparison of complete bacterial genomes","volume":"93","author":"Mushegian","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0007","series-title":"Bergey's manual of systematics of archaea and bacteria","article-title":"Tenericutes","author":"Brown","year":"2015"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0008","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1258\/0956462001916209","article-title":"The association of Chlamydia trachomatis and Mycoplasma genitalium with non-gonococcal urethritis: observations on heterosexual men and their female partners","volume":"11","author":"Keane","year":"2000","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinmicnews.2006.03.001","article-title":"The evolving saga of Mycoplasma genitalium","volume":"28","author":"Stein","year":"2006","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/sti.2005.017368","article-title":"Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment","volume":"82","author":"Ross","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0011","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0012","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1086\/593188","article-title":"Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance","volume":"47","author":"Jensen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0013","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jiac.2017.03.008","article-title":"Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan","volume":"23","author":"Deguchi","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02265-18","article-title":"Turning the tide against antibiotic resistance by evaluating novel, halogenated phenazine, quinoline, and NH125 compounds against Ureaplasma species clinical isolates and Mycoplasma type strains","volume":"63","author":"Valentine-King","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0015","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/ciy843","article-title":"Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis","volume":"69","author":"Romano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0016","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/sextrans-2018-053823","article-title":"Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis","volume":"95","author":"Cina","year":"2019","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0017","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s10096-018-3350-3","article-title":"Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations","volume":"37","author":"Braam","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0018","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jdv.13849","article-title":"2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0019","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0956462416648585","article-title":"2016 European guideline on the management of non-gonococcal urethritis","volume":"27","author":"Horner","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(18)30080-X","article-title":"Syndromic management of STIs and the threat of untreatable Mycoplasma genitalium","volume":"18","author":"Bradshaw","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0021","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1473-3099(06)70627-2","article-title":"Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications","volume":"6","author":"Gerrits","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0022","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ng.1034","article-title":"Evolutionary paths to antibiotic resistance under dynamically sustained drug selection","volume":"44","author":"Toprak","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0023","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.mib.2012.07.007","article-title":"Antimicrobials as promoters of genetic variation","volume":"15","author":"Bl\u00e1zquez","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0024","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/QCO.0000000000000030","article-title":"Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!","volume":"27","author":"Horner","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/14787210.2014.919220","article-title":"Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts","volume":"12","author":"Taylor-Robinson","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0026","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/cid\/ciw719","article-title":"Azithromycin 1.5g over 5 days compared to 1g single dose in urethral Mycoplasma genitalium: impact on treatment outcome and resistance","volume":"64","author":"Read","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0027","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1099\/mic.0.2008\/020735-0","article-title":"Interaction of Mycoplasma genitalium with host cells: evidence for nuclear localization","volume":"154","author":"Ueno","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0028","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010256","article-title":"Chlamydial intracellular survival strategies","volume":"3","author":"Bastidas","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0029","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1574-6968.2004.tb09488.x","article-title":"Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells","volume":"233","author":"Yavlovich","year":"2004","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.phrs.2012.06.001","article-title":"Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin","volume":"66","author":"Matija\u0161i\u0107","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0031","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrmicro3270","article-title":"Microbiological effects of sublethal levels of antibiotics","volume":"12","author":"Andersson","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0032","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2340\/00015555-2314","article-title":"Urethritis-associated pathogens in urine from men with non-gonococcal urethritis: a case\u2013control study","volume":"96","author":"Fr\u00f8lund","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 8","key":"10.1016\/j.ijantimicag.2020.105911_bib0033","doi-asserted-by":"crossref","first-page":"S802","DOI":"10.1093\/cid\/civ785","article-title":"Efficacy of antimicrobial therapy for Mycoplasma genitalium infections","volume":"61","author":"Manhart","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0034","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0035","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/ciu1162","article-title":"Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens","volume":"60","author":"Bissessor","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0036","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0037","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jac\/27.6.702","article-title":"From foreign pharmacopoeias: \u2018new\u2019 antibiotics from old?","volume":"27","author":"Hamilton-Miller","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0038","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1751-7915.2010.00213.x","article-title":"Characterization of the \u2018pristinamycin supercluster\u2019 of Streptomyces pristinaespiralis","volume":"4","author":"Mast","year":"2011","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0039","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/sti.2005.018598","article-title":"Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline","volume":"82","author":"Wikstr\u00f6m","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0040","doi-asserted-by":"crossref","first-page":"e61481","DOI":"10.1371\/journal.pone.0061481","article-title":"Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic","volume":"8","author":"Anagrius","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0041","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dkw405","article-title":"Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report","volume":"72","author":"Falk","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0042","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12879-015-1041-6","article-title":"Management of Mycoplasma genitalium infections\u2014can we hit a moving target?","volume":"15","author":"Jensen","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0043","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/JCM.00003-06","article-title":"Sequence-based typing of Mycoplasma genitalium reveals sexual transmission","volume":"44","author":"Hjorth","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0044","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/JCM.01602-08","article-title":"Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium","volume":"47","author":"Musatovova","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0045","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/jac\/dkv246","article-title":"Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women","volume":"70","author":"Falk","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0046","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/sextrans-2011-050035","article-title":"Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin","volume":"87","author":"Ito","year":"2011","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0047","article-title":"De novo mutations drive the spread of macrolide resistant Mycoplasma genitalium: mathematical modelling study","author":"Cadosch","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0048","doi-asserted-by":"crossref","first-page":"E2774","DOI":"10.1073\/pnas.1210309109","article-title":"Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0049","first-page":"377","article-title":"Evolution of mycoplasmas and genome losses","volume":"56","author":"Neimark","year":"1983","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02115648","article-title":"What are mycoplasmas: the relationship of tempo and mode in bacterial evolution","volume":"21","author":"Woese","year":"1985","journal-title":"J Mol Evol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0051","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0052","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrmicro1265","article-title":"The bacterial ribosome as a target for antibiotics","volume":"3","author":"Poehlsgaard","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0053","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0054","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jac\/dkv136","article-title":"High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment","volume":"70","author":"Nijhuis","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0055","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/JCM.00495-13","article-title":"Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium","volume":"51","author":"Tagg","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0056","first-page":"147","article-title":"Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations","volume":"8","author":"Couldwell","year":"2015","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0057","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1365-2958.2007.05975.x","article-title":"Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli","volume":"66","author":"Zaman","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0058","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12879-015-0781-7","article-title":"Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin","volume":"15","author":"Guschin","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175763","article-title":"Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia","volume":"12","author":"Shipitsyna","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/AAC.45.1.319-323.2001","article-title":"Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae","volume":"45","author":"Depardieu","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0061","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1128\/AAC.45.10.2958-2960.2001","article-title":"Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis","volume":"45","author":"Furneri","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0062","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/39.suppl_1.59","article-title":"A review of the in-vitro activity of quinupristin\/dalfopristin against intracellular pathogens and mycoplasmas","volume":"39","author":"B\u00e9b\u00e9ar","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0063","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s002840010106","article-title":"Specific inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells by 16-membered macrolide, lincosamide, and streptogramin B antibiotics","volume":"41","author":"Champney","year":"2000","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0064","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/jmbi.1998.2509","article-title":"Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23S rRNA and the synergism of their inhibitory mechanisms","volume":"286","author":"Porse","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/jmbi.1994.0135","article-title":"Fine structure of the peptidyl transferase centre on 23S-like rRNAs deduced from chemical probing of antibiotic\u2013ribosome complexes","volume":"247","author":"Rodriguez-Fonseca","year":"1995","journal-title":"J Mol Biol"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2020.105911_bib0066","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1086\/319370","article-title":"Mechanisms of action of antimicrobials: focus on fluoroquinolones","volume":"32","author":"Hooper","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0067","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","article-title":"Mechanism of fluoroquinolone action","volume":"2","author":"Drlica","year":"1999","journal-title":"Curr Opin Microbiol"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2020.105911_bib0068","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","article-title":"Quinolone molecular structure\u2013activity relationships: what we have learned about improving antimicrobial activity","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0069","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0027-5107(91)90095-6","article-title":"Mechanism of quinolone mutagenicity in bacteria","volume":"248","author":"Gocke","year":"1991","journal-title":"Mutat Res"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jiac.2018.08.009","article-title":"Surveillance of the prevalence of macrolide and\/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan","volume":"24","author":"Deguchi","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0071","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0956462416688562","article-title":"Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection","volume":"28","author":"Li","year":"2017","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198355","article-title":"Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains","volume":"13","author":"Hamasuna","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0073","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance","volume":"36","author":"Shimada","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0074","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1128\/AAC.49.3.1190-1193.2005","article-title":"In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively","volume":"49","author":"Gruson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jac\/dkp218","article-title":"Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism","volume":"64","author":"Beeton","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0076","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijantimicag.2010.07.013","article-title":"gyrB and parE mutations in urinary Mycoplasma genitalium DNA from men with non-gonococcal urethritis","volume":"36","author":"Shimada","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0077","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s002030050339","article-title":"Tetracyclines: antibiotic action, uptake, and resistance mechanisms","volume":"165","author":"Schnappinger","year":"1996","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0078","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1515\/hsz-2013-0292","article-title":"Tetracycline antibiotics and resistance mechanisms","volume":"395","author":"Nguyen","year":"2014","journal-title":"Biol Chem"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0079","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1073\/pnas.1208037109","article-title":"Structural basis for TetM-mediated tetracycline resistance","volume":"109","author":"D\u00f6nh\u00f6fer","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0080","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/AAC.03876-14","article-title":"16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis","volume":"59","author":"Amram","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0081","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/AAC.42.7.1702","article-title":"16S rRNA mutation associated with tetracycline resistance in a Gram-positive bacterium","volume":"42","author":"Ross","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0082","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/jac\/dkn118","article-title":"Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae","volume":"61","author":"D\u00e9grange","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0083","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0084","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/AAC.33.12.2144","article-title":"Tetracyclines as antiparasitic agents: lipophilic derivatives are highly active against Giardia lamblia in vitro","volume":"33","author":"Edlind","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0085","series-title":"Kucers\u2019 the use of antibiotics sixth edition: a clinical review of antibacterial, antifungal and antiviral drugs, Volume 1","first-page":"851","article-title":"Doxycycline","author":"Eisen","year":"2010"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0086","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.meegid.2011.10.017","article-title":"Mycoplasma genitalium: a comparative genomics study of metabolic pathways for the identification of drug and vaccine targets","volume":"12","author":"Butt","year":"2012","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0087","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0088","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","article-title":"Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0089","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/jac\/dky022","article-title":"In vitro activity of zoliflodacin (ETX0914) against macrolide-resistant, fluoroquinolone-resistant and antimicrobial-susceptible Mycoplasma genitalium strains","volume":"73","author":"Dami\u00e3o Gouveia","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0090","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/00222615-47-12-1115","article-title":"Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro","volume":"47","author":"Hannan","year":"1998","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0091","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0956462418816757","article-title":"Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline","volume":"30","author":"Glaser","year":"2019","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10156-012-0487-3","article-title":"Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing","volume":"19","author":"Hamasuna","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0093","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0094","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1128\/JB.183.23.6898-6907.2001","article-title":"Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA","volume":"183","author":"Garza-Ramos","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0095","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/JCM.02168-16","article-title":"Evaluation of a commercial multiplex quantitative PCR (qPCR) assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations in clinical specimens","volume":"55","author":"Le Roy","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0096","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00886-19","article-title":"Multicenter clinical evaluation of a novel multiplex real-time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium","volume":"57","author":"Fern\u00e1ndez-Huerta","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0097","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/jac\/dku164","article-title":"Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan","volume":"69","author":"Kikuchi","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0098","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/JCM.00370-17","article-title":"High macrolide resistance in Mycoplasma genitalium strains causing infection in Auckland, New Zealand","volume":"55","author":"Basu","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0099","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202428","article-title":"Mycoplasma genitalium in the Far North Queensland backpacker population: an observational study of prevalence and azithromycin resistance","volume":"13","author":"Trevis","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0100","first-page":"399","article-title":"Prevalence and antimicrobial resistance of Mycoplasma genitalium infection among women living with HIV in South Africa: a prospective cohort study","volume":"91","author":"Ong","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0101","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/cid\/ciu217","article-title":"Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey","volume":"59","author":"Salado-Rasmussen","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0102","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/cid\/cit752","article-title":"High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options","volume":"58","author":"Pond","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0103","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3201\/eid2209.160446","article-title":"Fluoroquinolone-resistant Mycoplasma genitalium, Southwestern France","volume":"22","author":"Le Roy","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0104","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jac\/dkw584","article-title":"High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands","volume":"72","author":"Braam","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2016.07.005","article-title":"Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany","volume":"86","author":"Dumke","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0106","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0956462418764482","article-title":"Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland","volume":"29","author":"Hokynar","year":"2018","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0107","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/OLQ.0000000000000940","article-title":"Prevalence, macrolide resistance and fluoroquinolone resistance in Mycoplasma genitalium in men who have sex with men (MSM) attending an STD clinic in Dublin, Ireland in 2017\u20132018","volume":"46","author":"Mulligan","year":"2019","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0108","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0956462415587418","article-title":"Mycoplasma genitalium: a possible case of macrolide resistance from Lebanon","volume":"27","author":"Maatouk","year":"2016","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0109","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/OLQ.0000000000000617","article-title":"Mycoplasma genitalium antibiotic resistance-mediating mutations in Canadian women with or without Chlamydia trachomatis infection","volume":"44","author":"Chernesky","year":"2017","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijantimicag.2020.105911_bib0110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12879-018-3523-9","article-title":"Macrolide-resistant Mycoplasma genitalium infections in Cuban patients: an underestimated health problem","volume":"18","author":"Mondeja","year":"2018","journal-title":"BMC Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:37:01Z","timestamp":1760377021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0924857920300509"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105911","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of antimicrobial resistance in Mycoplasma genitalium","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105911"}}